Tempus AI's Strong Q2 Fuels Growth Story—More Upside Ahead?

Over the past two years, one of the most interesting healthcare companies to go public is none other than Tempus AI NASDAQ: TEM. In a world where healthcare IPOs are typically dominated by biotech companies that generate little to no revenue, Tempus stands out. Tempus AI TodayTEMTempus AI$69.63 +3.29 (+4.96%) 52-Week Range$31.36▼$91.45Price Target$65.36Add to WatchlistThe firm has posted sales of approximately $952 million over the last twelve months and has made strong improvements in profitability. The s ...